Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -44.26% | 36.90% | |||
| Depreciation & Amortization | -6.62% | -11.70% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.27% | 20.96% | |||
| Operating Income | -49.27% | -20.96% | |||
| Income Before Tax | -35.89% | -19.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.89% | -19.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -48.99% | -21.78% | |||
| Net Income | -40.06% | -22.99% | |||
| EBIT | -49.27% | -20.96% | |||
| EBITDA | -50.93% | -22.31% | |||
| EPS Basic | 35.13% | 14.09% | |||
| Normalized Basic EPS | 24.98% | 12.28% | |||
| EPS Diluted | 35.13% | 14.09% | |||
| Normalized Diluted EPS | 24.98% | 12.28% | |||
| Average Basic Shares Outstanding | 115.93% | 43.14% | |||
| Average Diluted Shares Outstanding | 115.93% | 43.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||